Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Adrenergic signaling in cardiomyocytes
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Adrenergic signaling in cardiomyocytes
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 3 | Arrhythmogenic right ventricular cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Arrhythmogenic right ventricular cardiomyopathy
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬3. Arrhythmogenic right ventricular cardiomyopathy
|
||||||||||||||||||||||||||||||||
| 4 | Arrhythmogenic right ventricular cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Arrhythmogenic right ventricular cardiomyopathy
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 5 | Cardiac muscle contraction 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Cardiac muscle contraction
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬5. Cardiac muscle contraction
|
||||||||||||||||||||||||||||||||
| 6 | Cardiac muscle contraction 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Cardiac muscle contraction
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 7 | Dilated cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Dilated cardiomyopathy
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬7. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||
| 8 | Dilated cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Dilated cardiomyopathy
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 9 | Hypertrophic cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Hypertrophic cardiomyopathy
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬9. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||
| 10 | Hypertrophic cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Hypertrophic cardiomyopathy
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 11 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬MAPK signaling pathway
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬11. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
| 12 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬MAPK signaling pathway
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
||||||||||||||||||||||||||||||||
| 13 | Oxytocin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Gabapentin Gabapentin 💬Oxytocin signaling pathway
| Gabapentin | 006 7件: 6 , 13, 18, 19, 70, 226, 298 💬13. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||
| 14 | Oxytocin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 9 diseases |
CACNA2D3 1件: CACNA2D3 💬Adrenergic signaling in cardiomyocytes
|
Pregabalin Pregabalin 💬Oxytocin signaling pathway
| Pregabalin | 013 5件: 13, 36, 46, 70, 298 💬
|
Adrenergic signaling in cardiomyocytes
1 gene, 2 drugs (DrugBank) and 9 diseases
Arrhythmogenic right ventricular cardiomyopathy
1 gene, 2 drugs (DrugBank) and 9 diseases
Cardiac muscle contraction
1 gene, 2 drugs (DrugBank) and 9 diseases
Dilated cardiomyopathy
1 gene, 2 drugs (DrugBank) and 9 diseases
Hypertrophic cardiomyopathy
1 gene, 2 drugs (DrugBank) and 9 diseases
MAPK signaling pathway
1 gene, 2 drugs (DrugBank) and 9 diseases
Oxytocin signaling pathway
1 gene, 2 drugs (DrugBank) and 9 diseases